A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT03078933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Prospective, Multi-Center Feasibility Study of APT001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The clinical trial will assess the delivery of Nitric Oxide topically to the diabetic foot ulcer wound and the surrounding wound area as it related to wound healing. The objective of the study is to assess the Nitric Oxide Therapy treatment time (the number of minutes to deliver the treatment) and frequency (number of days per week to treat) to determine the most optimal treatment time and frequency to develop a rationale for safety and efficacy for the final APT001 clinical study.
Study identification
- NCT ID
- NCT03078933
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Standard of Care Device
- Nitric Oxide Therapy 2x week 6 min. plus standard of care Device
- Nitric Oxide Therapy 2x week 12 min. plus standard of care Device
- Nitric Oxide Therapy 4x week 6 min. plus standard of care Device
- Nitric Oxide Therapy 4x week 12 min. plus standard of care Device
Device
Eligibility (public fields only)
- Age range
- 22 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2017
- Primary completion
- Apr 30, 2018
- Completion
- Jun 30, 2018
- Last update posted
- Jun 6, 2017
2017 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Montgomery | Alabama | 36111 | Recruiting |
| Clinical Site | Phoenix | Arizona | 85015 | Recruiting |
| Clinical Site | Tucson | Arizona | 85634 | Recruiting |
| Clinical Site | Fresno | California | 93721 | Recruiting |
| Clinical Site | Los Angeles | California | 90001 | Recruiting |
| Clinical Site | San Francisco | California | 94115 | Recruiting |
| Clinical Site | Sylmar | California | 91342 | Recruiting |
| Clinical Site | Cooper City | Florida | 33024 | Recruiting |
| Clinical Site | Miami | Florida | 33031' | Recruiting |
| Clinical Site | Miami | Florida | 33032 | Recruiting |
| Clinical Site | Boston | Massachusetts | 02118 | Recruiting |
| Clinical Site | West Columbia | South Carolina | 29033 | Recruiting |
| Clinical Site | Corpus Christi | Texas | 78401 | Recruiting |
| Clinical Site | San Antonio | Texas | 78229 | Recruiting |
| Clinical Site | Webster | Texas | 78245 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03078933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 6, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03078933 live on ClinicalTrials.gov.